| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Correcting QT for Heart Rate When Both are Affected by a Drug
|
Ferber, Georg
|
|
2018
|
42 |
3 |
p. 335-337
|
artikel
|
| 2 |
Correction to: Implications of Individual QT/RR Profiles—Part 1: Inaccuracies and Problems of Population-Specific QT/Heart Rate Corrections
|
Malik, Marek
|
|
2019
|
42 |
3 |
p. 473
|
artikel
|
| 3 |
Correction to: Implications of Individual QT/RR Profiles—Part 2: Zero QTc/RR Correlations Do Not Prove QTc Correction Accuracy in Studies of QTc Changes
|
Malik, Marek
|
|
2019
|
42 |
3 |
p. 475
|
artikel
|
| 4 |
Drug-Induced Liver Injury: Highlights of the Recent Literature
|
Real, Mark
|
|
2018
|
42 |
3 |
p. 365-387
|
artikel
|
| 5 |
Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017
|
Ehlken, Birgit
|
|
2019
|
42 |
3 |
p. 463-471
|
artikel
|
| 6 |
Implications of Individual QT/RR Profiles—Part 1: Inaccuracies and Problems of Population-Specific QT/Heart Rate Corrections
|
Malik, Marek
|
|
2018
|
42 |
3 |
p. 401-414
|
artikel
|
| 7 |
Implications of Individual QT/RR Profiles—Part 2: Zero QTc/RR Correlations Do Not Prove QTc Correction Accuracy in Studies of QTc Changes
|
Malik, Marek
|
|
2019
|
42 |
3 |
p. 415-426
|
artikel
|
| 8 |
Pharmacoepidemiologic Evaluation of Birth Defects from Health-Related Postings in Social Media During Pregnancy
|
Golder, Su
|
|
2018
|
42 |
3 |
p. 389-400
|
artikel
|
| 9 |
Pharmacovigilance in India: Present Scenario and Future Challenges
|
Kalaiselvan, V.
|
|
2018
|
42 |
3 |
p. 339-346
|
artikel
|
| 10 |
Potential Direct Costs of Adverse Drug Events and Possible Cost Savings Achievable by their Prevention in Tuscany, Italy: A Model-Based Analysis
|
Convertino, Irma
|
|
2018
|
42 |
3 |
p. 427-444
|
artikel
|
| 11 |
Preventing Future Deaths from Medicines: Responses to Coroners’ Concerns in England and Wales
|
Ferner, Robin E.
|
|
2018
|
42 |
3 |
p. 445-451
|
artikel
|
| 12 |
Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular Development
|
Abramova, Nadezda
|
|
2018
|
42 |
3 |
p. 453-461
|
artikel
|
| 13 |
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?
|
Trifirò, Gianluca
|
|
2018
|
42 |
3 |
p. 347-363
|
artikel
|
| 14 |
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?
|
Trifirò, Gianluca
|
|
|
42 |
3 |
p. 347-363
|
artikel
|
Tijdschrift beschrijving